Statement EUPHA

Statement by EUPHA and WEMOS to EUPHA members and the wider public health community: advocate sharing of rights, know-how and technology to maximise COVID-19 vaccine production

24 June 2021 2 min readtime

To end the COVID-19 pandemic as soon as possible and prevent unnecessary further loss of lives, everyone in the world needs access to safe and effective vaccines. The current vaccine supply is insufficient – at this rate, some countries will not be in a position to access vaccines until 2024. Therefore, the manufacturing capacity needs to be maximised. We need more available, certified pharmaceutical companies to use their factories to produce vaccines. To enable them to do so, current vaccine makers must share their intellectual property rights (such as patents), know-how and technology with other pharmaceutical companies.

More info

Related articles

Subscribe to our newsletter

Subscribe to our newsletter

We periodically send out interesting information relating to our section in the form of news, facts and details of conferences and meetings.

To stay up-to-date and be a part of our activities, please subscribe to our section using the subscribe button below.

Subscription to

We periodically send out interesting information relating to our project in the form of news, facts and details of conferences and meetings.

To stay up-to-date and be a part of our activities, please subscribe to our project using the subscribe button below.